LinkedIn Twitter Facebook
Medication Compliance and Persistence: Terminology and Definitions

Medication Compliance and Persistence: Terminology and Definitions

The citation for this report is:
Cramer JA, Roy A, Burrell A, et al. Medication Compliance and Persistence: Terminology and Definitions. Value Health 2008;11: 44-7.

Chair:
Joyce A. Cramer, BS, Yale University School of Medicine, New Haven, CT, USA

Leadership Group:
Anuja Roy, MBA, MSc, West Virginia University, Morgantown, WV, USA
Anita Burrell, MBA, Sanofi-Aventis, Paris, France
Carol J. Fairchild, PhD, Alcon Laboratories, Ft. Worth, TX, USA
Mahesh J. Fuldeore, PhD, RPh, MBA, TAP Pharmaceuticals, Lake Forest, IL, USA
Daniel A. Ollendorf, MPH, PharMetrics, Watertown, MA, USA
Peter K. Wong, PhD, RPh, MS, MBA, Mercy Health Partners, Southwest Ohio, Cincinnati, OH, USA


ISPOR MEDICATION COMPLIANCE AND PERSISTENCE SPECIAL INTEREST GROUP (MCP)

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2012 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.